✦ LIBER ✦

Sertraline in contraceptive users with premenstrual dysphoric disorder

✍ Scribed by Candace S. Brown; Nicole Parker; Frank Ling; Jim Wan

Book ID: 117189347
Publisher: Lippincott Williams and Wilkins
Year: 2000
Tongue: English
Weight: 117 KB
Volume: 95
Category: Article
ISSN: 0029-7844
DOI: 10.1016/s0029-7844(00)00636-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of sertraline for treatment of

Efficacy of sertraline for treatment of premenstrual dysphoric disorder

✍ Anna L. Stout; John F. Steege; Tana A. Grady; Barbara Parry; Jean Endicott 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 196 KB

Sertraline efficacy in the treatment of

Sertraline efficacy in the treatment of premenstrual dysphoric disorder (PMDD)

✍ R.Rodriguez Castro; S.Ros Montalban; J.R.Domenech Bisen; J. De la Torre Hemandez 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Efficacy of intermittent, luteal phase s

Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder

✍ Uriel Halbreich; Richard Bergeron; Kimberly A Yonkers; Ellen Freeman; Anna L Sto 📂 Article 📅 2002 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 337 KB

Premenstrual Syndrome and Premenstrual D

Premenstrual Syndrome and Premenstrual Dysphoric Disorder in Adolescence

✍ Faith Claman; Terri Miller 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 336 KB

Treatment of premenstrual dysphoric diso

Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation

✍ Teri B. Pearlstein; Gloria A. Bachmann; Howard A. Zacur; Kimberly A. Yonkers 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 557 KB

Treatment of premenstrual dysphoric diso

Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation

✍ Teri B. Pearlstein; Gloria A. Bachmann; Howard A. Zacur; Kimberly A. Yonkers 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 557 KB

## Purpose: This multicenter, double-blind, placebo-controlled crossover study evaluated the efficacy of a new oral contraceptive (oc) formulation containing drospirenone 3 mg and ethinyl estradiol (ee) 20 mug in treating symptoms of premenstrual dysphoric disorder (pmdd). ## Method: The oc formu